Zimbabwe has turned down a major US health deal valued at $367m (£272m) spanning five years because of Washington's request for sensitive biological samples.
This rejection was revealed following a government memo dated December was leaked, revealing that President Emmerson Mnangagwa felt the deal was "unbalanced".
An official spokesperson has since clarified that the United States was demanding access to health data for scientific study and profit but was not willing to share the resulting advantages from future vaccines.
"We will now turn to the challenging and unfortunate task of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had donated over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for further talks to reach a agreement acceptable to all parties so the nation's critical HIV programme can continue.
Wider Background
This rejection comes after a similar situation in Kenya, where a high court blocked a related deal with the US following legal challenges were filed about the safety of Kenyans' medical information.
After returning to office last year, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump argued its expenditure was "inefficient" and his government was seeking direct bilateral deals to boost transparency and responsibility.
According to statements, Sixteen African countries have so far signed similar agreements, constituting over $18.3bn in new funding.
Specifics of the Declined Deal
The funds for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration might have yielded extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment via American-funded initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, with no equivalent promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.
"Effectively, our nation would supply the basic resources for scientific discovery without any assurance that the final treatments would be accessible to our population if a new health crisis arise."
Sovereignty and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were undermining systems previously established through the international health agency.
Mangwana cited its Pandemic Benefit-Sharing scheme designed to deal with future global health emergencies.
"This mechanism is intended to guarantee that when a nation contributes its data, the benefits – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to create them."
Zimbabwe's reservations over the US deal "are not meant as hostility towards the US," he added.
"We are open to continued dialogue with our American counterparts on how future collaboration might be structured in a way that respects the sovereignty and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but recommended that negotiations must proceed since much of the country's HIV programmes were funded by external financing.
"Where specific concerns arise, such as those relating to information security or agreement terms, these can often be addressed via detailed discussion and mutually agreed protections," the group commented.
The halted deal underscores the ongoing tensions between receiving crucial foreign assistance and safeguarding local interests in an increasingly data-driven world.